Kadokawa Corporation (TYO:9468)

Longboard Pharmaceuticals Income Statement

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	276,899	277,915	258,109	255,429	221,208	209,947
Revenue Growth (YoY)	4.44%	7.67%	1.05%	15.47%	5.36%	2.59%
Cost of Revenue	179,637	178,840	171,496	164,573	145,621	136,256
Gross Profit	97,262	99,075	86,613	90,856	75,587	73,691
Selling, General & Admin	84,281	82,382	68,158	64,978	57,465	60,055
Other Operating Expenses	-	-	-	-	-	113
Operating Expenses	84,322	82,423	68,158	64,925	57,067	60,065
Operating Income	12,940	16,652	18,455	25,931	18,520	13,626
Interest Expense	-89	-80	-63	-123	-100	-103
Interest & Investment Income	1,824	2,006	2,159	1,257	512	597
Earnings From Equity Investments	785	725	554	629	463	-86
Currency Exchange Gain (Loss)	-3,477	-1,794	1,763	308	1,339	19
Other Non Operating Income (Expenses)	317	117	-2,746	-1,450	-597	256
EBT Excluding Unusual Items	12,300	17,626	20,122	26,552	20,137	14,309
Gain (Loss) on Sale of Investments	1,194	2,769	1,861	-91	-13	487
Gain (Loss) on Sale of Assets	95	116	331	159	132	244
Asset Writedown	-266	-266	-2,562	-3,735	-71	-216
Other Unusual Items	-509	-3,055	-59	-1,533	-728	-568
Pretax Income	12,814	17,190	19,693	21,352	19,457	14,256
Income Tax Expense	3,234	7,253	6,671	6,153	4,396	4,745
Earnings From Continuing Operations	9,580	9,937	13,022	15,199	15,061	9,511
Minority Interest in Earnings	-2,784	-2,545	-1,638	-2,520	-983	73
Net Income	6,796	7,392	11,384	12,679	14,078	9,584
Net Income to Common	6,796	7,392	11,384	12,679	14,078	9,584
Net Income Growth	-38.19%	-35.07%	-10.21%	-9.94%	46.89%	18.35%
Shares Outstanding (Basic)	140	137	136	139	133	124
Shares Outstanding (Diluted)	141	137	136	140	133	124
Shares Change (YoY)	4.02%	0.56%	-2.17%	4.99%	7.32%	-0.54%
EPS (Basic)	48.45	53.86	83.42	90.91	105.96	77.41
EPS (Diluted)	46.85	52.47	83.42	90.89	105.96	77.41
EPS Growth	-42.25%	-37.10%	-8.22%	-14.22%	36.87%	18.99%
Free Cash Flow	-	7,202	-	14,709	19,497	-1,444
Free Cash Flow Per Share	-	52.48	-	105.44	146.74	-11.66
Dividend Per Share	30.000	30.000	30.000	30.000	25.000	20.000
Dividend Growth	-	-	-	20.00%	25.00%	33.33%
Gross Margin	35.13%	35.65%	33.56%	35.57%	34.17%	35.10%
Operating Margin	4.67%	5.99%	7.15%	10.15%	8.37%	6.49%
Profit Margin	2.45%	2.66%	4.41%	4.96%	6.36%	4.57%
Free Cash Flow Margin	-	2.59%	-	5.76%	8.81%	-0.69%
EBITDA	21,498	24,907	25,374	32,059	24,622	18,155
EBITDA Margin	7.76%	8.96%	9.83%	12.55%	11.13%	8.65%
D&A For EBITDA	8,558	8,255	6,919	6,128	6,102	4,529
EBIT	12,940	16,652	18,455	25,931	18,520	13,626
EBIT Margin	4.67%	5.99%	7.15%	10.15%	8.37%	6.49%
Effective Tax Rate	25.24%	42.19%	33.88%	28.82%	22.59%	33.28%
Advertising Expenses	-	10,935	-	9,390	7,419	13,710

Source: S&P Global Market Intelligence. Standard template. Financial Sources.